| Serial Number | 79300661 |
| Word Mark | HELIXMITH |
| Filing Date | Wednesday, November 11, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 2, 2021 |
| Registration Number | 6541689 |
| Registration Date | Tuesday, November 2, 2021 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 17, 2021 |
| Description of Mark | The mark consists of the wording "HELIXMITH" in which the letter "X" is formed by a helix design. |
| Goods and Services | Pharmaceutical preparations for health care for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; Crude medicines for treating neurological diseases, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related disease; Pharmaceutical preparations extracted from crude medicine for treating neurological diseases, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; reagents for use in veterinary genetic testing; dietary supplement drinks; dietary supplements; chemical preparations for pharmaceutical purposes for treating chemical imbalances; Gene therapy preparations for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, or cancer; Drugs for medical purposes for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; chemical preparations for use in dna analysis for medical diagnostic purposes; Biological preparations for medical for veterinary purposes for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, or cancer; reagents for use in medical genetic testing; Pharmaceutical drugs for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; Medicines for human purposes for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; Pharmaceutical preparations for diagnosis for cancer or renal diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; Ethical medicinal preparations for the treatment of neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; nutraceutical preparations for therapeutic or medical purposes; Therapeutic drugs and agents for the treatment of neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; health functional food being dietetic foods mainly based on Korean herbal medicines |
| Goods and Services | Retail store services featuring reagents for use in veterinary genetic testing; retail store services featuring chemical preparations for pharmaceutical purposes; wholesale store services featuring gene therapy preparations; retail store services featuring gene therapy preparations; retail services by direct solicitation by sales agents in the field of gene therapy preparations; retail store services featuring chemical preparations for use in DNA analysis for medical purposes; retail store services featuring biological preparations for medical or veterinary purposes; retail store services featuring drugs for medical purposes; retail store services featuring reagents for use in medical genetic testing; retail store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for the treatment of immune system related diseases and disorders; retail store services featuring ethical medicinal preparations; wholesale store services featuring therapeutic drugs and agents; retail store services featuring therapeutic drugs and agents |
| Goods and Services | Research and development of vaccines and medicines; biotechnological research; development of new products for others in the field of biotechnology; scientific research in the fields of biomedicine; Scientific research and chemical testing services in the fields of bacteriology and virology; drug discovery services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical products development; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; research of pharmaceuticals; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine, health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 28, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 28, 2020 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 28, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Helixmith Co., Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | Helixmith Co., Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | Helixmith Co., Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Monday, May 16, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, April 25, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, April 25, 2022 | FINAL DISPOSITION PROCESSED |
| Wednesday, February 2, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, November 2, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 17, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 17, 2021 | PUBLISHED FOR OPPOSITION |
| Sunday, August 15, 2021 | NOTIFICATION PROCESSED BY IB |
| Wednesday, July 28, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, July 28, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, July 28, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, July 14, 2021 | ASSIGNED TO LIE |
| Wednesday, July 14, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, July 13, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 13, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 13, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 17, 2021 | REFUSAL PROCESSED BY IB |
| Tuesday, April 27, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, April 27, 2021 | REFUSAL PROCESSED BY MPU |
| Saturday, April 24, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, April 23, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 21, 2021 | ASSIGNED TO EXAMINER |
| Friday, January 1, 2021 | APPLICATION FILING RECEIPT MAILED |
| Monday, December 28, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, December 24, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |